Fundraising Fox
Myomo
NYSE: MYOCambridge, US · Delaware corporation · 1 known investors
Find your way into Myomo
Sign up to see every warm intro you have to Myomo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Myomo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.
Founders & leadership
PR
Paul R. GudonisChairman & Chief Executive OfficerPaul R. Gudonis has held leadership roles spanning software, telecommunications, Internet services, and robotics sectors, including founding positions at venture-backed companies and executive roles at public corporations. He served as a robotics education advocate and now leads Myomo as Chairman and CEO, commercializing wearable robotic orthoses for stroke and spinal cord injury rehabilitation.
SK
Steve KellyNamed on SEC filing
Board
TK
Thomas KirkBoard director
BS
Byron SmithBoard director
TA
Thomas A. Crowley, Jr.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 3 rounds · 2014–2016
▶$200KraisedJul 2016 · 2 investors · Other Health CareRule 506(b)
▶$200KraisedJul 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Byron SmithDirector
- Davie MendelsohnExecutive Officer
- Thomas KirkDirector
- Steve KellyExecutive Officer, Director
- Paul GudonisExecutive Officer, Director
- Jonathan NaftExecutive Officer
- Thomas A. Crowley, Jr.Director
- Offering amount
- $3M
- Amount sold
- $200K
- Placement agents
- Healthios Capital Markets, LLC, Tripoint Global Equities, LLC
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$620KraisedJan 2016 · 6 investors · Other Health CareRule 506(b)
▶$620KraisedJan 2016 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KirkDirector
- Byron SmithDirector
- Paul GudonisExecutive Officer, Director
- Thomas A. Crowley, Jr.Director
- Steve KellyExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $620K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedAug 2014 · 37 investors · Other Health CareRule 506(b)
▶$1.7MraisedAug 2014 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve KellyExecutive Officer, Director
- Paul GudonisExecutive Officer, Director
- Byron SmithDirector
- Thomas A. Crowley, Jr.Director
- Offering amount
- $5.3M
- Amount sold
- $1.7M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
NeurolutionsNeurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.
Ispot TviSpot is an advertising technology platform that provides TV ad analytics and intelligence for media companies and advertisers.
Companies working in the same space as Myomo.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $144.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Myomo do?
- Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.
- Who are Myomo's investors?
- Myomo's investors include Boston Harbor Angels.
- How much funding has Myomo raised?
- Myomo has disclosed $2.5M raised across 3 rounds.
- Where is Myomo headquartered?
- Myomo is headquartered in Cambridge, US.